ClinicalTrials.gg
CompletedNCT01794728HELP-HFUpdated Nov 3, 2015

How the Elderly Live With Pain in Heart Failure

An observational study in Heart Failure, sponsored by Thomas Jefferson University. Completed at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2015-11-03.

Sponsored by Thomas Jefferson University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
56
Ages
60 Years and older
Sex
All
01

Study summary

The How the Elderly Live with Pain in Heart Failure (HELP-HF) study provides the opportunity to assess the complaints of pain in a cohort of HF patient admitted to Thomas Jefferson University Hospital (TJUH). Additional information on their existing co-morbid conditions, an inventory of their prescribed medications, and details regarding the type of treatment interventions (over the counter analgesia and other comfort practices) they report using will be collected.

Read the detailed description

Study Events Patients admitted to TJUH with a HF diagnosis will be identified by intensive clinical research coordinator screening methods. The potential subjects will be approached in the acute care area for interview and consent to participate. At that visit, the variables of interest will be collected and the questionnaires completed. Following discharge, the subjects will be re-interviewed at follow-up clinic visits or by telephone, depending on whether the visit is to a Jefferson University Physician provider or to an outside provider or as circumstances allow.

Subjects will sign an informed consent to participate in HELP-HF. A selection of assessment questionnaires (listed below) and performance measures will be completed during the index hospitalization and at a subsequent follow up clinic visits or by telephone call. Some of these assessments involve data collection from standard of care encounters or tests and will be abstracted from the medical record.

The Kansas City Cardiomyopathy Questionnaire (KCCQ) The KCCQ is a valid, reliable and responsive health status measure for HF patients and serves as a clinically meaningful outcome assessment tool that is widely used in cardiovascular research, patient management, and quality of life self-assessment.12 The Brief Pain Inventory (BPI) The BPI is one of the most widely used measurement tools for assessing clinical pain. It allows patients to rate the severity of their pain and the degree to which their pain interferes with common dimensions of feeling and function. Initially developed to assess pain related to cancer, the BPI has validated as an appropriate measure for pain caused by a wide range of clinical conditions. , The Charlson Co-Morbidity Index (CCI) Comorbidity describes the effect of all other diseases an individual patient might have other than the primary disease of interest. The CCI is used to characterize comorbid medical conditions and allows inferences about the extent to which symptoms and other factors related to quality of life may be attributable to conditions other than HF. The CCI designates comorbid conditions in 19 categories and each category has an associated weight based on the adjusted risk of one-year mortality, and the overall comorbidity score reflects the cumulative increased likelihood of one-year mortality. Charlson scores can range between 0 and 35, with a higher score indicating increase in burden of comorbid disease.

OTC Medication Inventory A comprehensive list of any over the counter (OTC) medications will be collected and reconciled via review of the electronic medical records and by subject interview.

Brief Interventions Measures (BIM) The BIM questionnaire is a novel tool developed for use in the HELP-HF study. It is adapted from similar questionnaires used in palliative oncology care and incorporates an inventory of comfort measure identified in the literature. These include measures like application of heat or cold, massage, and other self-selected therapies.

Case Report Form and Data Capture A paper case report form (data collection tool) will be developed for each subject's study records. All data will be entered by study personnel into a password-protected database using the REDCap (Research Electronic Data Capture) system. REDCap is a secure, web-based application designed to support electronic data capture for research studies. REDCap is used by selected areas within the University. It is a service available via a free collaboration with the NIH CTSA structure and accessed at TJU with permission and oversight via internal Information Systems at the University's Kimmel Cancer Center. REDCap allows for monitored dual data entry via a web-based system that is maintained on a protected server and will be used by the study investigators, coordinators and statistician.

Statistical Analyses Plan Subject demographics and co-morbidities as well as characteristics of the self-reported pain, treatment selections, and efficacy will be reported as medians and interquartile ranges (IQRs) for continuous variables and as percentages of non-missing values for categorical variables. Patients will be stratified by pain scores. Univariate comparisons between patients with and without pain will be performed using the Pearson χ2 test for categorical variables and the Wilcoxon rank-sum test for continuous and ordinal variables.

02

Conditions studied

  • Heart Failure

Keywords

  • Pain Management
03

In context

Heart Failure

5,801 studies on the registry are indexed under Heart Failure; 1,222 are open to participants now.

This study's enrollment of 56 is below the median of 200 across 1,719 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

Thomas Jefferson University is the lead sponsor of 390 studies on the registry; 72 are open to participants now.

Of its 45 completed or terminated interventional studies of FDA-regulated products, 21 (47%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Men and women age 60 or greater hospitalized with acute decompensated heart failure.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men and women ≥ 60 years.
  • Admission to hospital for worsening HF

Exclusion criteria

Exclusion Criteria:

  • History of uncontrolled hypertension.
  • Severe valve disease.
  • End-stage (Stage D) HF, including treatment with chronic ionotropic drugs or left ventricular assist device support.
  • Advanced malignancy or other medical condition with life expectancy less than 2 years or undergoing active chemotherapy or radiation therapy.
  • Advanced chronic kidney disease (CKD) defined as estimated glomerular filtration rate (GFR) \< 20 mL/min/1.73 m2 based upon the Modification of Diet in Renal Disease (MDRD) study equation), or on chronic or intermittent dialysis or dialysis anticipated within the next 6 months.
  • Chronic anemia with hemoglobin \< 9 gm/dl for males, \< 8 gm/dl for females or acute anemia requiring transfusion of 2 or more units of blood.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
56 participants (actual)
Patient registry
No

Groups and cohorts

  • Elderly inpatients with heart failure

    A single cohort group of elderly patients hospitalized for heart failure.

06

What researchers measure

Primary outcomes

  1. Change in characteristics and frequency of pain in a cohort of HF patients

    Assessment will be completed at baseline time of enrollment during hospitalization and again at 30 days after discharge. The instrument used is the Brief Pain Inventory questionnaire.

    Time frame: Time of enrollment date and after 30 days.

Secondary outcomes

  1. Change in the analgesia and comfort measures selected to treat pain by a cohort of HF patients

    Assessment will be completed at baseline time of enrollment during hospitalization and again at 30 days after discharge. The instrument used is a modified Pain Intervention Measurement questionnaire.

    Time frame: Time of enrollment date and after 30 days.

  2. Change in the relationship between pain and self- reported QOL in a cohort of HF patients

    Assessment will be completed at baseline time of enrollment during hospitalization and again at 30 days after discharge. The instrument used is the Kansas City Cardiomyopathy questionnaire.

    Time frame: Time of enrollment date and after 30 days.

07

Study locations

1 site
  • Thomas Jefferson University
    Philadelphia, Pennsylvania 19107, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2012, a primary completion of Jun 2013 and a completion of Jul 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 21, 2012
First posted
Feb 20, 2013
Start
Jul 2012
Primary completionActual
Jun 2013
CompletionActual
Jul 2013
Last update
Nov 3, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 3, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01794728
Responsible party
Sponsor
First posted
Feb 20, 2013
Start date
Jul 2012
Primary completion
Jun 2013
Completion
Jul 2013
Last update
Nov 3, 2015

Study contacts

David J Whellan, MD MHS
principal investigator · Thomas Jefferson University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion